Tolerability and side-effect profile of sertraline;Verträglichkeit und nebenwirkungsspektrum von sertralin

Psychopharmakotherapie

Volumn 4, Issue SUPPL. 7, 1997, Pages 26-32

  Reiff, Julia ^a   Laux, Gerd ^a   Müller, Walter E ^a   Möller, Hans Jürgen ^a  

^a Psychiatrische Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; CYTOCHROME P450 ISOENZYME; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSE RESPONSE; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; HEADACHE; HUMAN; INSOMNIA; MALE SEXUAL DYSFUNCTION; NAUSEA; NEUROTOXICITY; OUTPATIENT; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SOMNOLENCE; TREMOR; VERTIGO; XEROSTOMIA;

EID: 0031408427     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aguglia E, Casacchia M, Cassano GB, Faravelli V, et al. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int Clin Psychopharmacol 1993; 8:197-202.
2. Bennie E, Mullin JM, Martindale JJ. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. J Clin Psychiatry 1995;56:229-37.
3. Canadian Pharmaceutical Association, editor. Fluvoxamine maleate (Luvox). Compendium of pharmaceuticals and specialities. 30th ed. Ottawa, Ontario, Canada: 1995:737-8.
4. Coffey DJ, Jenkyn LR, Coffey AK, et al. Effects of sertraline, amitriptyline and placebo on cognitive and motor functioning in the elderly: a double-blind crossover study. Presented at XIXth Collegium Internationale Neuropsychopharmacologicum. Washington, DC, USA 1994;27 June-1 July.
5. Cohn CK, Shrivastava R, Mendels J. Double-blind multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990;51(Suppl. 12B):28-33.
6. Dinan TG. Lithium augmentation in sertraline-resistant depression. Acta Psychiatr Scand 1993;88:300-1.
7. Doogan DP, Caillard V. Sertraline in the prevention of depression. Br J Psychiatry 1992; 160:217-22.
8. Eric LT. A prospective double-blind comparative multicentre study of paroxetine and placebo in preventing recurrent major depression episodes. Biol Psychiatry 1991;29 (Suppl.11): 2545
9. Fabre LF, Abuzzahab FS, Amin M, Claghorn JL, et al. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 1995;38: 592-602.
10. Fontaine R. The efficacy and safety of sertraline versus imipramine in outpatients with major depression: a six month double-blind, parallel multicenter study. Presented at IVth European College of Neuropsychopharmacology. Monte Carlo, Monaco 1991;6-9 October.
11. Goodnick PJ, Henry JH, Buki VM. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995;56:128-36.
12. Hindmarch I, Shillingford B, Shillingford C. The effects of sertraline on psychomotor performance in elderly volunteers. J Clin Psychiatry 1990;12 (Suppl. B):34-6.
13. Latimer PR, Ravidran AV, Bernatchez JP, et al. A six month comparison of toleration and efficacy of sertraline and fluoxetine treatment of major depression. Presented at XX. CINP. Melbourne, Australia 1996;June-1996.
14. Lau GT, Horowitz BZ. Sertraline overdose. Academic Emergency Medicine 1996;3:132-6.
15. Leonard BE. Fundamentals of psychopharmacology. Chichester: John Wiley, 1992.
16. Mertens C, et al. A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression. Presented at the 148th American Psychiatric Association. Miami, Florida, USA 1995;20-25 May.
17. Montgomery SA. Progress on long-term management - report on an ICANP consensus. Presented at VIIth European College of Neuropsychopharmacology. Jerusalem, Israel 1994;16-21:October.
18. Montgomery SA, Dufour H, Brion S, Gailledreau J, et al. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 1988;153 (suppl. 3):69-76.
19. Nemeroff CB, Ballenger JC, et al. Safety and tolerance of fluvoxamine versus sertraline in depressed outpatients. Presented at VIIIth European College of Neuropsychopharmacology. Venice, Italy 1995;30 September-4 October.
20. Newhouse PA, Finkel SI, Richter EM. SSRI in the treatment of depressed outpatients aged 70 years and older. Presented at VIIIth European College of Neuropsychopharmacology. Venice, Italy 1995;30 September-4 October.
21. Newhouse PA, Richter EM. SSRI in depressed elderly: a double-blind comparison of sertraline and fluoxetine in depressed geriatric outpatients. Presented at VIIIth European College of Neuropsychopharmacology. Jerusalem, Israel 1994:16-21 October.
22. Pfizer Inc. Data on file. Study IRD II 1997.
23. Preskorn SH. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline and venlafaxine. J Clin Psychiatry 1995;56 (Suppl. 6):12-21.
24. Preskorn SH. Clinical pharmacology of selective scrotonin reuptake inhibitors. Caddo, Illinois, USA: Professional Communications Inc. 1996.
25. Preskorn SH, Janicau PG, Davis JM, et al. Advances in the pharmacotherapy of depressive disorders. In: Janicau PG, editor. Principles and practices of psychopharmacotherapy. Baltimore: Williams & Wilkins, 1995.
26. Reimherr FW, Chouinard G, Cohn CK, Cole JO, et al. Antidepressant efficacy of sertraline: a double-blind, placebo and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990;51 (Suppl. 12B):8-27.
27. Sechter D, Troy S, Rioux P. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients. Presented at XX. CINP. Melbourne, Australia 1996;June-1996.
28. Thompson C, Wiseman R, Lane R. Safety and efficacy of sertraline in elderly versus younger depressed patients in primary care. Presented at XIXth Collegium Internationale Neuropsychopharmacologicum. Washington, DC, USA 1994;27June-1 July.
29. van Moffaert M, Batholome F, Cosyns P, et al. A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression. Hum Psychopharmacol 1995;10:393-405.
30. Zanardi R, Franchini L, Gasperini M, Perez J, et al. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 1996;153:1631-3.